This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Meta-Analysis

. 2020 Feb;140(2):495-497.e5.

doi: 10.1016/j.jid.2019.07.712. Epub 2019 Aug 26.

Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis

Ahmed Mourad¹, Robert Gniadecki²

Affiliations

Affiliations

¹ Division of Dermatology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
² Division of Dermatology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada; Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Copenhagen, Denmark. Electronic address: r.gniadecki@ualberta.ca.

PMID: 31465745
DOI: 10.1016/j.jid.2019.07.712

Free article

Meta-Analysis

Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-Analysis

Ahmed Mourad et al. J Invest Dermatol. 2020 Feb.

Free article

. 2020 Feb;140(2):495-497.e5.

doi: 10.1016/j.jid.2019.07.712. Epub 2019 Aug 26.

Authors

Ahmed Mourad¹, Robert Gniadecki²

Affiliations

¹ Division of Dermatology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada.
² Division of Dermatology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Canada; Department of Dermatology, University of Copenhagen, Bispebjerg Hospital, Copenhagen, Denmark. Electronic address: r.gniadecki@ualberta.ca.

PMID: 31465745
DOI: 10.1016/j.jid.2019.07.712

No abstract available

PubMed Disclaimer

Comment in

Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?
Scarisbrick JJ. Scarisbrick JJ. J Invest Dermatol. 2020 Feb;140(2):281-283. doi: 10.1016/j.jid.2019.08.440. J Invest Dermatol. 2020. PMID: 31980062

Similar articles

The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.
Sanz-Bueno J, Lora D, Monsálvez V, Maroñas-Jiménez L, Postigo C, Rodríguez-Peralto JL, Ortiz-Romero PL. Sanz-Bueno J, et al. Br J Dermatol. 2016 Oct;175(4):794-6. doi: 10.1111/bjd.14559. Epub 2016 Jun 20. Br J Dermatol. 2016. PMID: 26990536 No abstract available.
Erythrocyte sedimentation rate as an independent prognostic factor in mycosis fungoides.
Hallermann C, Niermann C, Fischer RJ, Schulze HJ. Hallermann C, et al. Br J Dermatol. 2012 Apr;166(4):873-4. doi: 10.1111/j.1365-2133.2011.10729.x. Br J Dermatol. 2012. PMID: 22059808
Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
Nielsen PR, Eriksen JO, Wehkamp U, Lindahl LM, Gniadecki R, Fogh H, Fabricius S, Bzorek M, Ødum N, Gjerdrum LM. Nielsen PR, et al. Acta Derm Venereol. 2019 Dec 1;99(13):1231-1236. doi: 10.2340/00015555-3351. Acta Derm Venereol. 2019. PMID: 31620804
Folliculotropism Does Not Affect Overall Survival in Mycosis Fungoides: Results from a Single-Center Cohort and Meta-Analysis.
Giberson M, Mourad A, Gniadecki R. Giberson M, et al. Dermatology. 2017;233(4):320-325. doi: 10.1159/000484203. Epub 2017 Nov 24. Dermatology. 2017. PMID: 29169156 Review.
A review of survival in mycosis fungoides.
Vollmer RT. Vollmer RT. Am J Clin Pathol. 2014 May;141(5):706-11. doi: 10.1309/AJCPH2PHXFCX3BOX. Am J Clin Pathol. 2014. PMID: 24713743 Review.

See all similar articles

Cited by

Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA, Dubeibe Abril PA, Niebles Sincelejo OE, Reina HSL. Ariza Gómez SA, et al. An Bras Dermatol. 2024 May-Jun;99(3):407-413. doi: 10.1016/j.abd.2023.08.008. Epub 2024 Feb 22. An Bras Dermatol. 2024. PMID: 38395632 Free PMC article.
Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
Hristov AC, Tejasvi T, A Wilcox R. Hristov AC, et al. Am J Hematol. 2021 Oct 1;96(10):1313-1328. doi: 10.1002/ajh.26299. Epub 2021 Aug 2. Am J Hematol. 2021. PMID: 34297414 Free PMC article.
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
Luna DE, Shinohara MM. Luna DE, et al. Curr Hematol Malig Rep. 2023 Jun;18(3):83-88. doi: 10.1007/s11899-023-00692-w. Epub 2023 Apr 5. Curr Hematol Malig Rep. 2023. PMID: 37017872 Review.
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphoma.
Larocca C, Bui AN, O'Malley JT, Giobbie-Hurder A, Tawa M, Teague JE, Clark RA, Cutler C, Jacobsen E, Fisher DC, Kupper TS, LeBoeuf NR. Larocca C, et al. Blood Cancer J. 2025 Apr 17;15(1):69. doi: 10.1038/s41408-025-01237-5. Blood Cancer J. 2025. PMID: 40246811 Free PMC article.
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.
Hristov AC, Tejasvi T, Wilcox RA. Hristov AC, et al. Am J Hematol. 2025 Sep;100(9):1603-1628. doi: 10.1002/ajh.27735. Epub 2025 Jun 10. Am J Hematol. 2025. PMID: 40495407 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information